Tularik's IPO

Tularik raised a round of funding on March 20, 2000. Investors include Public.

Tularik is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform …

Articles about Tularik's IPO: